# No Resistance After Long Term Treatment SERETIDE

> **NCT00456313** · PHASE4 · WITHDRAWN · sponsor: **GlaxoSmithKline**

## Conditions studied

- Asthma

## Interventions

- **DRUG:** FLIXOTIDE and SERETIDE

## Key facts

- **NCT ID:** NCT00456313
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-12
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of data
- **Last updated:** 2015-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00456313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00456313, "No Resistance After Long Term Treatment SERETIDE". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00456313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*